期刊文献+

益肾除颤汤联合多巴丝肼片治疗帕金森病随机对照研究 被引量:19

Effect of Yishen Chuchan Decoction Combined with Madopar on Parkinson's Disease: A Randomized Controlled Trial
原文传递
导出
摘要 目的观察益肾除颤汤联合多巴丝肼片治疗帕金森病的疗效。方法将86例帕金森病患者按随机数字表法分为治疗组和对照组,每组43例,治疗组予多巴丝肼片加益肾除颤汤口服治疗,对照组予多巴丝肼片加安慰剂口服治疗,连续治疗2个月。观察患者治疗前及治疗1、2个月帕金森病运动功能评定量表评分(MDRSPD)、统一帕金森病评定量表第三部分(UPDRSⅢ)评分、计时运动试验次数、非运动症状评价量表(NMSS)评分、帕金森病非运动症状问卷(NMSQuest)评分,观察两组患者服药后的安全性指标。结果与本组治疗前比较,两组患者治疗2个月后MDRSPD、UPDRSⅢ评分降低(P<0.05,P<0.01),左、右手计时运动试验次数均升高(P<0.05,P<0.01);治疗组治疗1、2个月NMSS和NMSQuest评分降低(P<0.05,P<0.01)。与对照组同期比较,治疗组治疗2个月UPDRSⅢ评分降低(P<0.05),左、右手计时运动试验次数升高(P<0.05),治疗1、2个月NMSS和NMSQuest评分降低(P<0.05,P<0.01)。结论益肾除颤汤联合多巴丝肼片可改善帕金森病症状。 Objective To observe the clinical efficacy of Yishen Chuchan Decoction combined with Madopar on Parkinson' s disease. Methods Totally 8 6 patients with Parkinson' s Disease( PD) were randomized into two groups: the treatment group( 4 3 cases) and the control group( 4 3 cases). During two consecutive months, patients in the treatment group received Madopar and Yishen Chuchan Decoction while patients in the control group were given Madopar and placebo orally. The motor dysfunction rating scale for Parkinson' s disease( MDRSPD),unified Parkinson' s disease rating scale Ⅲ( UPDRS Ⅲ),nonmotor symptom scale( NMSS),performance in chronograph movement( times of left and right hand movement in one minute) and non-motor symptom questionnaire( NMSQuest) were reviewed at three time points: before treatment,treatment for 1 month and treatment for 2 months. The safety parameters of the two groups were also observed after treatment. Results MDRSPD scores and UPDRS scores of both groups decreased after 2 months treatment compared with those before treatment( P 0. 0 5,P 0. 0 1). Meanwhile,the frequency of chronograph movement of left or right hand increased( P 0. 0 5,P 0. 0 1). In treatment group,NMSS scores and NMSQuest scores decreased after 1 and 2 months compared with those before treatment( P 0. 0 5,P 0. 0 1). Compared with control group,the UPDRS scores decreased and the frequency of chronograph movement increased in treatment group after 2 months( P 0. 0 5). The NMSS scores and NMSQuest scores decreased after 1 and 2 months in treatment group compared with con-trol group( P 0. 0 5,P 0. 0 1). Conclusion Yishen Chuchan Decoction combined with Madopar could improve the symptoms of Parkinson' s disease.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2017年第9期1081-1084,共4页 Chinese Journal of Integrated Traditional and Western Medicine
基金 江苏省中医药局科技项目(No.LB09088)
关键词 帕金森病 益肾除颤汤 多巴丝肼片 帕金森病运动功能评定量表 非运动症状评价量表 Parkinson's disease Yingshen Chuchan Decoction Madopar motor dysfunction rating scale for Parkinson's disease Non-motor symptom scale
  • 相关文献

参考文献6

二级参考文献19

  • 1张燕辉,陈彪.运动功能检测对帕金森病早期诊断的意义[J].脑与神经疾病杂志,2005,13(2):155-156. 被引量:2
  • 2卞兆祥,李幼平,David MOHER,Simon DAGENAIS,刘良,吴泰相,缪江霞,关家伦,宋丽.提高中草药随机对照试验的质量Ⅰ:临床试验设计和方法学(英文)[J].中西医结合学报,2006,4(2):120-129. 被引量:37
  • 3窦永起,杨明会,刘毅,魏正茂.中西医结合治疗帕金森病疗效的对照观察[J].中国临床康复,2006,10(19):6-8. 被引量:28
  • 4陈海波 王新德(译).统一帕金森病评定量表(3.0版,1987)[J].中华老年医学杂志,1999,18:61-61.
  • 5Gibb UR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson' s disease. J Neurol Neurosurg Psychiatry. 1988; 51(6) : 745-752.
  • 6Leonard CT, Deshner WP, Romo JW, Suoja ES, Fehrer SC, Mikhailenok EL. Myotonometer intra- and interrater reliabilities. Arch Phys Med Rehabil. 2003; 84(6): 928- 932.
  • 7Warlow C. Advanced issues in the design and conduct of randomized clinical trials: the bigger, the better? Statistics in Medicine 2002 ; 21 : 2797--2805.
  • 8Carlin JB, Doyle LW. Statistics for clinicians. 7: Sample size. J Paediatr Child Health 2002 ; 38 : 300--304.
  • 9Pocock SJ. Clinical trims: A practical approach. 1st edition. Chichester: John Wiley & Sons Ltd. England, 1983:123--141.
  • 10Millar JA, Burke V. Relationship between sample size and the definition of equivalence in non-inferiority drug studies. Journal of Clinieal Pharmaey and Therapeutics 2002;27:329--333.

共引文献746

同被引文献233

引证文献19

二级引证文献138

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部